Kiniksa Pharmaceuticals · 16 hours ago
Senior Clinical Project Manager
Lexington, MA, US
Full-time
Onsite
Senior Level
$160K/yr - $180K/yr
7+ years expKiniksa Pharmaceuticals is seeking a Senior Clinical Project Manager to provide operational expertise within the Research and Development function. This role involves managing all operational aspects of clinical trials, ensuring compliance with regulations, and collaborating with various teams to support the timely execution of studies.
BiopharmaBiotechnologyMedical
Responsibilities
Independently managing all operational aspects for implementation of clinical trial activities from study start-up through database lock, with expertise in accelerating project launch and site start-up / activations, while ensuring adherence to protocol, GCPs and relevant SOPs
Leading internal cross-functional study teams and partner with CROs to ensure effective and timely communication, study execution in accordance with the timeline and budget
Actively participating in protocol design, CRO selection, site selection and IRB/EC applications for early and late phase clinical studies
Managing study-related vendors and serving as the primary point of contact for contracted CROs, study staff and contract labs; identifying potential risks and proactively resolving issues with CROs; establishing vendor management plans and reviewing quality metrics
Performing and/or overseeing site monitoring visits for clinical trials as needed
Facilitating the timely completion of study protocols (including amendments) and development (and revision) of electronic clinical trial systems (e.g., EDC, IRT)
Providing input into and/or developing study related materials such as Clinical Monitoring Plans, Data Management Plans, eCRF forms and completion guidelines, protocols, patient informed consent drafts, site instructions for specimen collections, and study drug order forms
Reviewing monitoring reports, protocol deviations and data listings for sponsored studies to ensure reliable quality data are delivered
Coordinating with CROs on site selection, IRB submissions, site initiation and close-out planning
Managing in a timely and efficient manner all operational aspects of protocol amendments
Developing and managing reports for communicating study progress and key metrics to Senior Management and program team
Coordinating the negotiation of site budgets within guidelines and providing oversight for site payments per contracts
Facilitating site study drug orders, and ensuring full drug chain record management, including site accountability records are maintained; Management of non-drug supply ordering and tracking, as required
Providing oversight and ensuring maintenance of clinical trial master files to ensure their compliance with required regulatory and ICH/GCP quality standards and consistency with SOPs
Providing input to Drug (IND) filings, Clinical Trial Applications, safety reports, clinical study reports and other ICH compliant sections of registration dossiers (e.g., BLA, MAA, NDA, etc.)
Providing oversight of clinical trials to ensure that all adverse events or product safety issues are captured, reported and evaluated by appropriate Clinical personnel in a timely manner
Establishing a system and procedure for forecasting (and reforecasting) needs for investigational product for each study and communicating those needs on a routine basis
Ensuring inspection readiness and participating with CROs and providing support to sites to prepare for clinical audits/inspections and to respond to audit/inspection findings conducted by internal QA and external regulatory agencies
Qualification
Required
Requires a Bachelor's Degree in health or biologic science (BS/BA/ BScN or higher); masters-level degree is preferred
A minimum of 7 years clinical operations experience at a sponsor or CRO, including 3 years as a clinical study lead / project manager is required; global clinical trial experience is required with cardiovascular, rare disease and/or Phase 1 experience highly preferred
Solid well-grounded experience in setup, execution and operational management of domestic and international Phase 1, 2, and/or 3 clinical trials across an array of therapeutic areas, including expertise in all aspects of investigational site start-up
Effective project management and risk management skills
Excellent listening, communication (written, spoken) and interpersonal skills, ability to foster team spirit
Advanced knowledge of Good Clinical Practices and current knowledge of FDA regulations for IND clinical trials is required; working knowledge of other country regulatory requirements is required
Extensive experience selecting and managing CROs and clinical trial vendors
Extensive experience in delivering clinical study reports with applicable appendices
Knowledge and experience in preparation of clinical sections of regulatory submissions (e.g., INDs, CTAs, BLAs, MAAs or NDAs), including data needed for completion of sections in eCTD Module 1
Ability to accurately forecast budgets and manage them across studies and projects
Proficient in use of electronic clinical database software and other programs such as Microsoft Office
Preferred
masters-level degree is preferred
global clinical trial experience is required with cardiovascular, rare disease and/or Phase 1 experience highly preferred
Site monitoring and clinical quality compliance experience are strongly preferred
Company
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
201-500 employees
H1B Sponsorship
Kiniksa Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (3)
2022 (4)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$400MKey Investors
Baker Brothers Advisors LLC
2020-05-13Post Ipo Equity· $80M
2018-05-23IPO
2018-02-01Series C· $200M
Leadership Team
Eben Tessari
Chief Operating Officer
Aaron Young
Senior Vice President, Chief Intellectual Property Officer
Recent News
GlobeNewswire
2026-01-13
2025-12-09
2025-10-29
Company data provided by crunchbase